“We have grown in line with the industry and faster than listed peers this quarter, which also led to market share improvement from 14.6% in Q1 to 15.0% in Q2 on a pre-merger basis,” Vibha Padalkar, MD and CEO was quoted as saying in the release.
Subscribe To Our Free Newsletter |